Transdermal Drug Delivery Systems Market By Application (Cardiovascular, Contraception, Pain Management / Neurological Disorders, Smoking Cessation, Others), By Technology (Electric Current, Electroporation, Radio Frequency, Thermal, Ultrasound, Others) and Geography

 

Transdermal Drug Delivery Systems Market size was valued at USD 53,721.5 million in 2021, growing at a CAGR of 5.1% from 2022 to 2028. Transdermal Drug Delivery Systems Market is the self-contained, discrete dosage applied in the form of patches to the intact skin and delivers medication through the controlled rate. The main aim of transdermal patches is to deliver the medication into the systemic circulation at controlled rates to minimize the intra and interpatient variation. Transdermal drug delivery methods enable systemic drug circulation and maintain clinically efficacious concentrations at a predefined pace with minimum inter-and intrapatient variation by delivering the drug through the skin. It's a medicated adhesive bandage that sticks to the skin and releases the medicine into the bloodstream. It lessens the strain on the digestive tract and liver that comes with taking pills orally. It increases therapeutic efficacy and safety, keeps drug levels stable in the blood, and solves the drawbacks of traditional oral dosage forms and parenteral formulations. The global market provides a detailed overview and which can be segmented by technology, application, and region. By technology, the transdermal drug delivery systems market has been segmented into electric current, electroporation, radio frequency, thermal, ultrasound, and others. By technology, the electroporation segment is expected to have a significant growth rate over the forecasted period due to the increasing high for electroporation technology in the field of transdermal drug delivery globally. Based on application, the segment has been segregated into cardiovascular, contraception, pain management / neurological disorders, smoking cessation, and others. By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.